D3 PLATFORM
D3 Platform
The chemical focus of the CNPD3 is on unique natural products, and the goal is to fully exploit the biosynthetic and therapeutic potential of untapped biodiversity for drug discovery. Candidate compounds are investigated for further development through interactive chemistry and pharmacology efforts. The center embraces all aspects of natural products research from discovery, biosynthesis and chemical synthesis, assay development, screening and target identification to drug development.
CNPD3 FOCUS AND RESEARCH
CNPD3 FOCUS AND RESEARCH
Microbial Genomics & Synthetic Biology
CNPD3 FOCUS AND RESEARCH
Molecular Diversity and Screening
CNPD3 FOCUS AND RESEARCH
Molecular Pharmacology
CNPD3 FOCUS AND RESEARCH
AI-based and Structure-based Drug Design & Optimization
CNPD3 FOCUS AND RESEARCH
Synthetic Chemistry
CNPD3 Focus and Research
PROTAC & Targeted Therapeutics
CNPD3 FOCUS AND RESEARCH
Botanical Translational Science
CNPD3 FOCUS AND RESEARCH
Animal Models of Disease
A New Wave of MEDICINE
Dr. Hendrik Luesch
Answering the Call
In an ocean of possibilities, Dr. Hendrik Luesch is answering the call to make the next great drug discovery. His work takes him below the surface of the sea, where new medicines harbor hope for a healthier tomorrow.
Play Video
CNPD3 Seminar series
CNPD3 Seminar Series | Dr. Steven Bloom
Wednesday, September 11th from 10:00 AM – 11:00 AM in C1-004. Dr.Bloom’s presentation title is “New Synthetic Tools for Peptide Medicinal Chemistry”
CNPD3 Seminar Series | Dr. Donna Zhang
Wednesday, August 28th, 10:00 AM – 11:00 AM in room C1-004 Dr. Zhang’s presentation is titled “Unraveling the intricacies of NRF2 in cancer”
CNPD3 Seminar Series | Dr. Tycho Heimbach
Wednesday, May 8th from 10:00 AM – 11:00 AM in Communicore C1-004 Dr. Heimbach’s presentation is titled ” Physiologically Based Biopharmaceutics Modeling (PBBM) and PBPK Applications in Drug Development and…
CNPD3 Seminar Series | Dr. Pablo Sobrado
Wednesday, April 24th 2024 from 10:00 AM – 11:00 AM in the Shands Auditorium 6120 Dr. Sobrado’s presentation is titled “Hydroxamate containing siderophores biosynthesis and inhibition”
DEPARTMENT NEWS
Genetics may predict benefits of kava in reducing lung cancer risk
Researchers bolstered their findings that kava may reduce lung cancer risk caused by tobacco smoke.
Department gathers to celebrate and bid farewell to Jim Rocca on his retirement
im Rocca will be retiring in October 2024 after serving UF as a research facility specialist at the McKnight Brain Institute for 26 years.
STRONGER internship program provides students with valuable exposure to cancer research
A new immersive summer internship at UF Health Cancer Center is helping science students from across the country explore cancer research.
Celebrating a Year of Achievements in Medicinal Chemistry
Recap some of the highlights from the 2023-24 academic year.